Zolindronic Acid in Osteoporosis- A Dexa Study
M. Vijay Balaji, Sathish Devadoss, A. Victor Devadoss, Sreekanth Gunti
Abstract
M. Vijay Balaji, Sathish Devadoss, A. Victor Devadoss, Sreekanth Gunti
Abstract
Background: Osteoporosis a systemic skeletal disease characterized by low bone mass and micro architectural deterioration of bone tissue leading to enhanced bone fragility and a consequent increase in fracture risk. We present our study analyzing the effect of Intravenous zolendronic therapy in osteoporotic individuals using the Dual Energy X-ray Absorptiometry Scan. Materials and method: All patients above 50 yrs of age with osteoporosis measured by DEXA Scan of Lumbar Spine BMD (T-score
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Background: Osteoporosis a systemic skeletal disease characterized by low bone mass and micro architectural deterioration of bone tissue leading to enhanced bone fragility and a consequent increase in fracture risk. We present our study analyzing the effect of Intravenous zolendronic therapy in osteoporotic individuals using the Dual Energy X-ray Absorptiometry Scan. Materials and method: All patients above 50 yrs of age with osteoporosis measured by DEXA Scan of Lumbar Spine BMD (T-score
Key concepts: Osteoporosis, Medicine, Dual energy, Bone mass, Lumbar spine, Fragility fracture, Dual-energy X-ray absorptiometry, Bone disease